Tablet PINAK given as treatment to COVID positive patients.

Ayurvedic proprietary adjuvant oral intervention Tab PINAK for COVID patients towards early recovery.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025326

Enrollment

Registered

2020-05-23

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B342- Coronavirus infection, unspecified

Interventions

Intervention1: Tab PINAK: Moderate to severe disease: 2 Stat

plus 1 QID x 5 days: Mild: 1 TDS X 5 days. If required to be continued: maximum 14 days intervention Control Intervention1: Not Applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patients reporting positive for COVID infection in COVID wsrd of SKNMC and GH Pune

Exclusion criteria

Exclusion criteria: Below 18 years of age, Pregnant and lactating women; Patients in ICU under ventilator.

Design outcomes

Primary

Measure	Time frame
Early recovery and reduced mortalityTimepoint: Day 15	—

Secondary

Measure	Time frame
Hospital stay reducedTimepoint: Day 15 or at discharge for any reason.	—

Countries

India

Contacts

Public ContactDr Pandurang Pawar

Shree Bharadi Ayurvedic Pharamaceuticals

drpandurangpawar@gmail.com8830207186

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026